Talk:Milrinone

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Milrinone.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Unlinked references[edit]

This was at the bottom in the "references" section:

Anonymous. Milrinone for Acute Exacerbations of CHF: Routine Use Not Recommended. Formulary Journal. May 2000;37(5): 227.
Sablotzki A, Starzmann W, Schebel R, Grond S and Czeslik E. Selective Pulmonary Vasodilation with Inhaled Aerosolized Milrinone in Heart Transplant Candidates. Canadian Journal of Anesthesia. 18 Apr 2005;52(10):1076-1083.
Smith A, Owen J, Borgman K, Fish F, and Kannankeril P. Relation of MIlrinone After Surgery for Congenital Heart Disease to Significant Postoperative Tachyarrhythmias. American Journal of Cardiology. 1 Dec 2011;108(11):1620-1624.
Yan C, Miller C and Abe, J. Regulation of Phosphodiesterase 3 and Inducible cAMP Early Repressor in the Heart. Circulation Research. 2007;100:589-501.
Yano M, Kohno M, Oskusa T, Mochizuki M, Yamada J, Kohno M et all. Effect of Milrinone On Left Ventricular Relaxation and Calcium Uptake Function of Cardiac Sarcoplasmic Reticulum. American Journal of Physiology. 9 May 2000;279(4):1898-1905.

None of them are WP:MEDRS-proof. JFW | T@lk 13:50, 8 September 2016 (UTC)[reply]

Moved from article[edit]

I have moved the following content here because it lacks context/explanation. If anyone wants to use it to improve the article, here it is. -- Ed (Edgar181) 23:14, 14 September 2016 (UTC)[reply]

[[File:Milrinone Synthesis.png|500px]] Singh, B.; 1983, {{US patent|4,413,127}}.

Use in stroke patients[edit]

This drug is being used to address vasospams in hemorrhagic stroke patients. Can someone write something about that? I'm not a medical person.

http://stroke.ahajournals.org/content/39/3/893

Thaks. Adamgoldberg (talk) 12:56, 27 August 2017 (UTC)[reply]